Spero Therapeutics Inc (SPRO)

Jul 23, 2025

What drives Spero Therapeutics Inc. stock priceConsistently outstanding ROI - jammulinksnews.com

Jul 23, 2025

Jul 23, 2025

What analysts say about Spero Therapeutics Inc. stockOutstanding capital appreciation - jammulinksnews.com

Jul 23, 2025

Jul 22, 2025

Spero Therapeutics Inc. Stock Analysis and ForecastConsistently superior profits - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Is Spero Therapeutics Inc. a good long term investmentFree Bull & Bear Market Updates - Autocar Professional

Jul 22, 2025

Jul 18, 2025

Will Spero Therapeutics Inc. stock benefit from AI tech trendsTrend Based Entry Alerts - Newser

Jul 18, 2025

Jul 18, 2025

When is the best time to buy Spero Therapeutics Inc. stockFree Real-Time Trading Opportunities - Newser

Jul 18, 2025

Jul 16, 2025

Insufficient Growth At Spero Therapeutics, Inc. (NASDAQ:SPRO) Hampers Share Price - simplywall.st

Jul 16, 2025

Jul 15, 2025

What makes Spero Therapeutics Inc. stock price move sharplyMarket Timing Advice - Newser

Jul 15, 2025

Jul 15, 2025

Why Spero Therapeutics Inc. stock attracts strong analyst attentionTop Momentum Stock Pick - Newser

Jul 15, 2025

Jul 15, 2025

How Spero Therapeutics Inc. stock performs during market volatilityBreakout Level Watch - Newser

Jul 15, 2025

Jul 01, 2025

Spero Therapeutics (NASDAQ:SPRO) Stock Passes Above Fifty Day Moving Average – What’s Next? - Defense World

Jul 01, 2025

Jun 28, 2025

While institutions own 20% of Spero Therapeutics, Inc. (NASDAQ:SPRO), retail investors are its largest shareholders with 54% ownership - Yahoo

Jun 28, 2025

Jun 25, 2025

Is Spero Therapeutics, Inc. overvalued or undervalued? - MarketsMojo

Jun 25, 2025

Jun 17, 2025

Complicated Urinary Tract Infection Pipeline Appears Robust With 12+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Globe and Mail

Jun 17, 2025

Jun 12, 2025

SPRO’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com

Jun 12, 2025

Jun 11, 2025

Spero TherapeuticsAdditional Upside Potential Following Positive Phase 3 Results (SPRO) - Seeking Alpha

Jun 11, 2025

Jun 11, 2025

Squarepoint Ops LLC Buys Shares of 55,051 Spero Therapeutics, Inc. (NASDAQ:SPRO) - Defense World

Jun 11, 2025

Jun 09, 2025

Spero Therapeutics COO Timothy Keutzer sells shares for $44,097 - MSN

Jun 09, 2025

Jun 09, 2025

Jane Street Group LLC Takes Position in Spero Therapeutics, Inc. (NASDAQ:SPRO) - Defense World

Jun 09, 2025

Jun 06, 2025

Spero Therapeutics Inc (SPRO) Is A Good Stock To Invest In - Stocksregister

Jun 06, 2025

Jun 06, 2025

Spero Therapeutics, Inc. (NASDAQ:SPRO) Stake Boosted by Mackenzie Financial Corp - Defense World

Jun 06, 2025

Jun 06, 2025

GSK, Spero Therapeutics Stop Antibiotic Trial For Complicated Urinary Tract Infections Early After Positive Results, Retail’s Thrilled - MSN

Jun 06, 2025

Jun 04, 2025

Northern Trust Corp Sells 25,050 Shares of Spero Therapeutics, Inc. (NASDAQ:SPRO) - Defense World

Jun 04, 2025

May 31, 2025

Why Spero Therapeutics, Inc. (SPRO) Surged Last Week - Insider Monkey

May 31, 2025

May 31, 2025

Spero Therapeutics stock hits 52-week high at $2.53 By Investing.com - Investing.com South Africa

May 31, 2025

May 31, 2025

Complicated Urinary Tract Infection Oral Antibiotic Approaches Approval - Vax-Before-Travel

May 31, 2025

May 30, 2025

Spero Therapeutics stock hits 52-week high at $2.53 - Investing.com India

May 30, 2025

May 30, 2025

Spero Therapeutics Jumps as Oral Carbapenem Hits Phase 3 Milestone - MSN

May 30, 2025

May 30, 2025

SPRO Stock Soars 245% on GSK-Partnered UTI Drug Meeting Study Goal - MSN

May 30, 2025

May 29, 2025

Spero Therapeutics Stock (SPRO) Rockets 225% on Clinical Trial Data - The Globe and Mail

May 29, 2025

May 29, 2025

Spero Therapeutics And 2 Other Promising Penny Stocks To Watch - Yahoo Finance

May 29, 2025

May 29, 2025

Spero Therapeutics rockets on positive Phase III study for tebipenem HBr - The Pharma Letter

May 29, 2025